A study by the Comprehensive Cancer Center Vienna of MedUni Vienna and Vienna General Hospital has taken a closer look at the effectiveness of common examination methods for the early detection of prostate cancer.
MorphoSys Enters into Business Combination Agreement to be Acquired by Novartis for € 2.7 Billion Equity Value – Biotech Investments
EQS-News: MorphoSys AG / Key word(s): Mergers & Acquisitions/Disposal MorphoSys Enters into Business Combination Agreement to be Acquired by Novartis for € 2.7 Billion Equity